Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 4Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Shock, Septic 1Sepsis 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization × Clear all
NCT01217385 2023-01-17

ACRIN6691

American College of Radiology Imaging Network

Phase NA Completed
60 enrolled 17 charts
Breast

Breast Neoplasms

NCT00574678 2021-08-05

ACT

University of Arkansas

Phase 1/2 Completed
150 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms

NCT00896623 2017-02-17

SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897

SWOG Cancer Research Network

Completed
1,577 enrolled
Breast

Breast Neoplasms

NCT00633750 2012-09-05

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
50 enrolled 9 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡